Table 1 The combination therapy of surgery and chemotherapy for rPENT
From: Primitive neuroectodermal tumor of the kidney: case report and review of literature
Patient | Age (years) | Gender | Diagnosis | Metastases | Treatment | Chemotherapeutic agents | Follow-up | Outcome |
|---|---|---|---|---|---|---|---|---|
14 | 16 | F | Right rPENT | No | Nephrectomy + chemotherapy | Ifosfamide Vincristine Vinblastine Dactinomycin Adriamycin | >4 years | Alive with complete remission |
25 | 26 | F | Right rPENT | Lung metastasesat 2 monthsafter nephrectomy | Nephrectomy + chemotherapy, After metastases: sorafenib | Vincristine Adriamycin Cyclophosphamide Ifosfamide Etoposide | 17 months | Alive with stabilized lung metastases |
36 | 21 | M | Rihgt rPENT | Liver metastasesat 6 monthsafter nephrectomy | Nephrectomy,After metastases: Chemotherapy + partial hepatectomy | Doxorubicin Ifosfamide Etoposide | 21 months | Alive |
47 | 9 | M | Right rPENT | No | Nephrectomy + chemotherapy | Vincristine Doxorubicin Cyclophosphamide Ifosfamide Etoposide | 10 months | Relapse in the paraspinal cervical region |